Showing results (1261-1270 of 1,338) with videos related to
Sort By:
Pageof 134
Nature Genetics|December 20, 2022
Spurious transcription causing innate immune responses is prevented by 5-hydroxymethylcytosineFan Wu, Xiang Li, Mario Looso, et al.Journal of Environmental Sciences (China)|March 21, 2021
Chemical formation and source apportionment of PM<sub>2.5</sub> at an urban site at the southern foot of the Taihang mountainsXiaoyong Liu, Mingshi Wang, Xiaole Pan, et al.The Journal of Allergy and Clinical Immunology|May 11, 2021
Neutralizing anti-IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in IgG4-related diseaseJustin A Jarrell, Matthew C Baker, Cory A Perugino, et al.The Journal of Clinical Investigation|January 29, 2020
Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosisTakashi Maehara, Naoki Kaneko, Cory A Perugino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2014
Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective studyWai-Kay Seto, Thomas S Y Chan, Yu-Yan Hwang, et al.Addiction (Abingdon, England)|November 10, 2025
Efficacy of combined varenicline and nicotine replacement therapy compared with varenicline or nicotine replacement therapy alone for smoking cessation: A systematic review and meta-analysisXinmei Zhou, Zhenxiao Huang, Qingqing Song, et al.Advanced Materials (Deerfield Beach, Fla.)|July 9, 2025
A Novel Time-Division Multiplexing Architecture Revealed by Reconfigurable Synapse for Deep Neural NetworksYu-Tao Li, Kui Xu, Yu-Zhe Ma, et al.Advanced Materials (Deerfield Beach, Fla.)|July 30, 2025
High-Performance p-Type 1D Van der Waals Electronics Prepared Through Solution ProcessingTianchao Guo, Xiangming Xu, Maolin Chen, et al.Advanced Materials (Deerfield Beach, Fla.)|December 29, 2016
Epitaxial Growth and Air-Stability of Monolayer Antimonene on PdTe<sub>2</sub>Xu Wu, Yan Shao, Hang Liu, et al.The Lancet. Rheumatology|January 22, 2024
Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trialCory A Perugino, Zachary S Wallace, Debra J Zack, et al.Pageof 134